The bioactivity of butyrate in CRC tumors is not fully understood, raising questions about why Fn known for its oncogenic properties, can synthesize butyrate, an anti‐inflammatory metabolite [50, 51]. The gene discussed is FN1; the disease is colorectal carcinoma.